NRP1 and glioma: Targeting the transmembrane domain of NRP1, a peptide corresponding to the NRP1 transmembrane domain, termed pTM-NRP1, shows antiangiogenic activity in a xenograft mouse model of glioma and inhibits breast cancer growth and metastasis [375,376].